Searchable abstracts of presentations at key conferences in endocrinology

ea0063p548 | Diabetes, Obesity and Metabolism 2 | ECE2019

Microbiota changes in type 2 diabetes patients intolerant to metformin after drug reintroduction

Munoz-Garach Araceli , Diaz-Perdigones Cristina Maria , Moreno-Indias Isabel , Molina-Vega Maria , Cornejo-Pareja Isabel , Tinahones Francisco J

Introduction and objectives: Metformin (MTF) is the most used oral antidiabetic drug for the treatment of type 2 diabetes (T2D). However, intolerance to drug is frequent and limits its use. There are controversies about the cause of this problem, the gut microbiota has been proposed to be responsible. The gradual introduction of MTF could exercise an adaptation of gut microbiota that would facilitate tolerance to MTF. In this study we evaluate the metabolic changes and gut mic...

ea0070aep475 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Descriptive analysis of body composition and phase angle (PA) in achondroplastic patients: Case-control study

Mª Vegas-Aguilar Isabel , Maria Cornejo Pareja Isabel , Leiva Gea Antonio , Tinahones Francisco J , Manuel García-Almeida Jose

Introduction: Data on body composition in patients with achondroplasia are scarce. The Phase Angle (PA) is a bioelectric measurement of our body cells. The PA is considered to be a global prognostic factor that gives information about cellular function in relation to body composition.Objectives: To describe body composition parameters PA, standardized PA (sPA), resistance (Rz), reactance (Xc), body cell mass (BCM), total body water (TBW), fat mass (FM), ...

ea0063p105 | Calcium and Bone 1 | ECE2019

Parathyroid carcinoma: identity with diagnostic difficulties and therapeutic strategies

Maria Diaz Perdigones Cristina , Maria Gomez Perez Ana , Maria Cornejo Pareja Isabel , Munoz Garach Araceli , Damas Fuentes Miguel , Molina Vega Maria , Maraver Selfa Silvia

Blackground: Parathyroid carcinoma is a malignant neoplasm affecting 0.5 to 5.0% of all patients suffering from primary hyperparathyroidism. This cancer continues to cause challenges for diagnosis and treatment because of its rarity, overlapping features with benign parathyroid disease.Case report: 50 years-old-woman, without relevant previous history. She begins to present asthenia, weakness of lower limbs, arthralgias, cramps and appearance of a painfu...

ea0070aep376 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Phase angle (PA) and body composition changes in obese patients with associated comorbidities (by AACE criteria) through a very low calorie diet (VLCD) program

Maria Cornejo Pareja Isabel , Ma Vegas-Aguilar Isabel , Fernández-Medina Beatriz , Tinahones Francisco J , García-Almeida Jose Manuel

Introduction: Obesity is defined as a chronic disease by AACE/ACE. Includes presence/severity of complications. VLCD diets induce relevant weight loss by improving these complications. PA is a bioelectric measure of the cell mass and it is marker a global prognostic factor of cellular functionalism.Methods: Case-control retrospective study of severe obesity in a weight loss program comparing intensive intervention (41 cases, VLCD 800 kcal/d, 1g protein/k...

ea0056p16 | Adrenal cortex (to include Cushing's) | ECE2018

Rare incidence of primary adrenocortical carcinosarcoma: a case report

Maria Diaz Perdigones Cristina , Maria Cornejo Pareja Isabel , Damas Fuentes Miguel , Molina Vega Maria , Hernandez Garcia Carmen , Munoz Garach Araceli , Jose Tinahones Madueno Francisco

Introduction: Adrenal tumors are common tumors with a prevalence of around 3% in a population over the age of 50 years. In contrast, adrenocortical carcinoma (ACC) is a rare malignancy (incidence 1–2 per 1 million population) with a heterogeneous presentation and a variable but generally bad prognosis. Patients present with evidence of adrenal steroid hormone excess in approximately 60% of cases.Case report: A 49-year-old woman with symptoms of faci...

ea0037ep483 | Diabetes (complications & therapy) | ECE2015

Once-weekly exenatide in a real-world clinical setting: clinical outcomes and analysis of potential predictors of response

del Mar Roca-Rodriguez Maria , Fernandez-Garcia Jose Carlos , Cortes-Salazar Carmen Maria , Moya-Carmona Isabel , Gomez-Perez Ana Maria , Cornejo-Pareja Isabel , Munoz-Garach Araceli , Molina-Vega Maria , Doblas Isabel Mancha , Tinahones Francisco

Objective: The aim of this study is to evaluate the effectiveness of once-weekly exenatide on metabolic control, weight, blood pressure, and lipid profile in obese patients with type 2 diabetes (T2DM), and to assess possible predictive factors of response.Material and methods: Retrospective observational study, conducted with adult obese (BMI ≥30 kg/m2) T2DM subjects that had been initiated once-weekly exenatide following routine clinica...

ea0037ep1262 | Clinical Cases–Thyroid/Other | ECE2015

New treatments of diabetes: a promising alternative to bariatric surgery in obese patients

Roca-Rodriguez M Mar , Mancha-Doblas Isabel , Picon-Cesar M Jose , Gomez-Perez Ana Maria , Cornejo-Pareja Isabel , Molina-Vega Maria , Diaz-Perdigones Cristina , Olveira-Fuster Gabriel , Tinahones Francisco J

Introduction: New treatments of diabetes improve global metabolic status beyond glycemic control and achieve weight reduction in many patients.Case reports: We described four case reports to show GLP-1 agonists and dapaglifozin effects on metabolism and weight in patients with type 2 diabetes and obesity.Case 1 (Liraglutide): A 48-year-old man, hypertension, type 2 diabetes and extreme obesity. Baseline visit: treatment enalapril 2...